...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of the Cobas-Bact system for direct and rapid identification and antimicrobial susceptibility testing of gram-negative rods from positive blood culture broths.
【24h】

Evaluation of the Cobas-Bact system for direct and rapid identification and antimicrobial susceptibility testing of gram-negative rods from positive blood culture broths.

机译:对Cobas-Bact系统的评估,用于直接,快速鉴定和阳性血液培养肉汤中的革兰氏阴性杆菌的药敏试验。

获取原文

摘要

A direct antimicrobial susceptibility test and a direct identification of positive blood culture broths for gram-negative rods confirmed with Gram stain by using a new instrument, Cobas-Bact, were compared with the conventional Kirby-Bauer agar diffusion disk method and with the in-house set of identification or API 20E, respectively. The bacterial pellet of centrifuged positive blood culture broth was used to inoculate a Cobas-Bact susceptibility and identification rotor. Bacteria from 206 cases of monomicrobial septicemia due to members of the family Enterobacteriaceae were tested. In 198 episodes (96%), direct identification and antimicrobial susceptibility testing results were obtained for the same bacterial pathogen within 5 h of detection. Of 204 direct identifications obtained, 177 (86.6%) were "high-confidence" correct identifications (percentage of likelihood [P] greater than or equal to 80%) and 25 (12.5%) "low-confidence" correct identifications (P less than 80%), whereas only 2 misidentifications occurred (1 Escherichia coli and 1 Proteus mirabilis). Direct susceptibility testing was performed in 199 episodes (96%), providing 1,885 antibiotic-microorganism combinations. Full agreement reached 86.3%, and essential agreement reached 92.8%. Minor discrepancies were found in 120 (6.5%) of the tests, major discrepancies were found in 127 (6.8%) tests, and very major discrepancies were found in only 7 (0.4%) tests. Subsequent MIC determinations in cases of major or very major discrepancies reduced the number of major discrepancies involving cephalosporins from 60 to 16, whereas all those involving aminoglycosides remained. Overall, this direct and rapid Cobas-Bact identification and susceptibility testing procedure offered accurate information with 5 to 6 h after the laboratory detection of bacteremia and septicemia due to members of the Enterobacteriacease.
机译:通过使用新型仪器Cobas-Bact与传统的Kirby-Bauer琼脂扩散盘法以及直接在实验室中进行的比较,直接进行了药敏试验,并通过革兰氏染色证实的革兰氏阴性菌直接鉴定了阳性血培养肉汤。房屋标识或API 20E集。离心的阳性血液培养液的细菌沉淀用于接种Cobas-Bact敏感性和鉴定转子。测试了206例由于肠杆菌科成员导致的单药败血症的细菌。在198次发作(96%)中,在检测到的5小时内就对同一细菌病原体获得了直接鉴定和抗菌药敏试验的结果。在获得的204个直接识别中,有177个(86.6%)是“高置信度”正确识别(可能性[P]的百分比大于或等于80%)和25个(12.5%)是“低置信度”正确识别(小于P)超过80%),而只有2个错误识别(1个大肠杆菌和1个奇异变形杆菌)。在199次发作(96%)中进行了直接药敏试验,提供了1,885种抗生素-微生物组合。完全同意达到86.3%,基本同意达到92.8%。在120(6.5%)个测试中发现了较小的差异,在127(6.8%)个测试中发现了重大差异,而在7个(0.4%)测试中发现了非常重大的差异。随后在重大或非常重大差异的情况下对MIC的测定将涉及头孢菌素的重大差异的数量从60个减少到16个,而所有涉及氨基糖苷类的重大差异仍然存在。总的来说,这种直接,快速的Cobas-Bact鉴定和药敏测试程序可在实验室检测到肠杆菌科细菌引起的菌血症和败血病后5至6小时内提供准确的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号